Mrs. Palak Karia


  • DesignationAssistant Professor

    Date of Joining: 01/09/2022

    Employee Code: VESCOP074

    Employee ID: 37741

    Email ID: palak.karia@ves.ac.in

  • Educational Qualifications

    M. Pharm in Quality Assurance

    B. Pharm


    Academic Affiliations
    • Currently working as Assistant professor (Ad-hoc) in Vivekanand Education Society’s College of Pharmacy
    • Worked as Lecturer (Ad-hoc) in Saraswati vidya Bhawan’s College of Pharmacy

    Professional Affiliations
    Pharmacy Council of India

  • Teaching

    • Pharmacology
    • Anatomy Physiology and Pathophysiology
    • Clinical Pharmacy
  • Research
    Area Of Research

    • Preclinical studies in CNS, CVS.
    • Metabolic Disease studies
    • In-vitro testing of herbals
    • Toxicity studies

  •     Publications

    1. Book chapter entitled “Risk assessment, an essential tool for Quality by Design of Pharmaceuticals” published in technical journal named ‘Spinco Biotech Cutting Edge’.

    2. Research article entitled “Quantitative Determination of Zileuton from Spiked Human Plasma Using Liquid-Liquid Extraction Followed by RP-HPLC and UV Analysis” International Journal of Pharmaceutical Quality Assurance, Volume 14, Issue 1, 1 – 6.

    Patents:

    Patent filed on “A topical formulation of disease-modifying antirheumatic drug (dmards) for treatment of rheumatoid arthritis, melanoma, squamous cell carcinoma, atopic dermatitis and psoriasis” with other authors.

  • Title of Industrial Projects:

    Academic Year

    Industry

    Amount Sanctioned

    A topical formulation of disease- modifying antirheumatic drug

    2022

    Esha Therapeutics

    -

    Dapsone – In vitro release studies

    2023

    Teledyne hanson

    160000

    Acyclovir – Permeation studies

    2023

    Teledyne hanson

    80000

  • Awards and Honors

    1. Finalist in Disso India 2023.

    2. Research proposal selected in 15th Inter-Collegiate convention in Avishkar Research Convention

    3. Awarded with Student of the year as 2nd runner up organized by IPA-MSB-SF at Rx ERA in the year 2018-2019

    4. Stood first place in poster presentation (Rx 2017- 2018)

/* */